Lake Pointe Medical Center Now Offering LUTONIX ® 035 Drug Coated Balloon

ROWLETT, Texas - Nov. 12, 2014 - PRLog -- Lake Pointe Medical Center (http://www.lakepointemedical.com/en-US/Pages/default.aspx)(LPMC) today announced the availability of the Lutonix ^® 035 Drug Coated Balloon PTA Catheter (DCB), the first and only DCB approved by the U.S. Food and Drug Administration (FDA) for percutaneous transluminal angioplasty, after pre-dilatation, of de novo or restenotic lesions up to 150mm in length in native superficial femoral or popliteal arteries with reference vessel diameters of 4-6mm.

Peripheral Arterial Disease (PAD) in the femoropopliteal artery, a life-threatening condition, affects millions of Americans by narrowing arteries and reducing blood flow to the limbs, according to American Heart Association (AHA) estimates.[1] (http://#_ftn1) Patients with PAD in the femoropopliteal arteries are at risk for lower-extremity amputation, particularly in people over the age of 50.[2] (http://#_ftn2) Minimally-invasive endovascular procedures such as angioplasty balloons and stents, medications and vascular bypass surgery are some of the accepted ways to treat PAD, but these options may be limited depending on the type of arterial blockage.

Successful treatment of PAD requires improved blood flow (patency) for longer periods of time. A recent clinical study demonstrated superior primary patency with the Lutonix ^® 035DCB for the efficacy endpoint.

“We are committed to bringing innovations in care to our patients and we are excited to be one of the first hospitals in Dallas/Fort Worth to offer this new treatment option to our patients,” said Dr. Franklin Yau, vascular surgeon on the medical staff at LPMC.  “The Lutonix ^® 035 DCB is a new first-line therapy for treating blockages without closing the door to other treatment options down the road, an important consideration as we help our patients manage this painful, progressive and debilitating disease.”

Related Links:

http://www.loveyourlimbs.com

http://www.lutonix.com

ABOUT LAKE POINTE MEDICAL CENTER

Lake Pointe Medical Center is a 112-bed acute care hospital located at 6800 Scenic Drive in Rowlett.  Lake Pointe Medical Center has been serving the region’s healthcare needs since 1987.  The hospital provides a wide spectrum of medical services, including an emergency department with Fast Track services, a 14-bed intensive care unit, women's services, a Level II and Level III NICU, interventional cardiology, diagnostic imaging and eight operating rooms.  With a medical staff of more than 450 physicians, Lake Pointe Medical Center provides most specialty services.  The hospital holds CIGNA Center of Excellence Designations for laparoscopic gall bladder removal, chronic obstructive pulmonary disease (COPD), general cardiac medical, heart attack, heart failure, irregular heartbeat, stroke and vaginal delivery.  The hospital is designated as a Primary Stroke Center by the Joint Commission and a Level IV Trauma Center by the Texas Department of State Health Services. In 2011, 2012 and 2013 Lake Pointe Medical Center was named one of the nation’s top performers on key quality measures by The Joint Commission. The hospital is accredited by the Joint Commission, the nation’s oldest and largest hospital accreditation agency, licensed by the state of Texas and certified for participation in the Medicare and Medicaid programs.  To learn more about Lake Pointe Medical Center, visit www.lakepointemedical.com. Follow us on Twitter (https://twitter.com/LakePointeMC) and Facebook (https://www.facebook.com/LakePointeMC).

[1] (http://#_ftnref1) Why PAD Matters – American Heart Association Web site. Available at: http://www.heart.org/HEARTORG/Conditions/More/PeripheralArteryDisease/Why-PAD-Matters_UCM_301303_Article.jsp.

[2] (http://#_ftnref2) Peripheral Arterial Disease – NIH National Heart, Lung, and Blood Institute. Available at: https://www.nhlbi.nih.gov/health/health-topics/topics/pad.